Published • loading... • Updated
BioNTech SE (BNTX) Q3 2026 Earnings Call Transcript
Summary by Seeking Alpha
5 Articles
5 Articles
Biotechnology company posts $206.5M net profit as lower legal expenses offset declining COVID-19 vaccine revenue
·Ankara, Türkiye
Read Full Article
German biotechnology company BioNTech returned to profitability in the third quarter of 2026, reporting a net profit of €184.5 million. The company raised its year-end revenue forecast to between €1.7 billion and €1.9 billion.
In the third quarter, Biontech benefits from US partner Bristol Myers Squibb. This has a positive impact on the revenue forecast.
·Düsseldorf, Germany
Read Full ArticleCoverage Details
Total News Sources5
Leaning Left1Leaning Right2Center0Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium
